NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

精準醫學 (精密醫療) 軟體市場 - 各部署模式,各用途,各終端用戶:至2028年的預測

Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 1009566
出版日期 內容資訊 英文 125 Pages
訂單完成後即時交付
價格
精準醫學 (精密醫療) 軟體市場 - 各部署模式,各用途,各終端用戶:至2028年的預測 Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028
出版日期: 2021年06月02日內容資訊: 英文 125 Pages
簡介

精準醫學 (精密醫療) 軟體市場,預計至2028年達到25億5,000萬美元,2021年∼2028年以11.2%的年複合成長率成長。治療的模式轉移,醫療費削減的壓力高漲,基因學領域的科學技術進步,各種治療領域的搭配診斷和生物標記的提供受到高度的關注等成為市場成長主要原因。

本報告提供全球精準醫學 (精密醫療) 軟體市場相關調查分析,市場考察,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
    • COVID-19的影響評估

第5章 全球精準醫學 (精密醫療) 軟體市場:各部署模式

  • 簡介
  • 內部部署
  • Web、雲端基礎

第6章 全球精準醫學 (精密醫療) 軟體市場:各用途

  • 簡介
  • 腫瘤學
  • 醫藥基因學 (藥理基因學)
  • 其他

第7章 全球精準醫學 (精密醫療) 軟體市場:各終端用戶

  • 簡介
  • 醫療提供者
  • 研究、政府機關
  • 製藥、生物科技企業

第8章 全球精準醫學 (精密醫療) 軟體市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 南美
  • 中東、非洲

第9章 競爭情形

  • 簡介
  • 主要成長策略
  • 競爭基準

第10章 企業簡介

  • 2bprecise LLC (A Part of Allscripts Healthcare Solutions Inc.)
  • PierianDx, Inc.
  • PhenoTips
  • Foundation Medicine, Inc.
  • N-of-One Inc.
  • GenomOncology, LLC
  • Translational Software, Inc.
  • LifeOmic Health, LLC
  • Syapse, Inc.
  • Fabric Genomics, Inc.
  • Sophia Genetics SA
  • Human Longevity, Inc.
  • Sunquest Information Systems, Inc. (A Part of Roper Technologies, Inc.)

第11章 附錄

目錄

Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028.

The global precision medicine software market is expected to grow at a CAGR of 11.2% from 2021 to 2028 to reach 2.55 billion by 2028.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the precision medicine software market is mainly attributed to the paradigm shift in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, and growing focus towards providing companion diagnostics & biomarkers for various therapeutic areas. Moreover, emerging countries and AI in precision medicine provide growth opportunities for players operating in the precision medicine software market.

Based on deployment mode, the precision medicine software market is categorized into on-premise and web & cloud-based. In 2020, the on-premise segment accounted for the largest share of the precision medicine software market. The large share of this segment is primarily attributed to the broad range of advantages associated with the use of on-premise software, such as high security of data, low risk of data breaches, and full command over software upgrades & data storage. In addition, higher adoption among end-users and flexibility with connection bandwidth further support the growth of the segment.

Based on application, the precision medicine software market is mainly segmented into oncology, pharmacogenomics, central nervous system disorders, hereditary disorders, and cardio & metabolic disorders. In 2020, the oncology segment accounted for the largest share of the global precision medicine software market. The large share of this segment is primarily attributed to the growing prevalence of cancer, shift towards personalized treatment, rising funding in cancer research, applications of precision medicine in oncology research, and increased investments by government organizations in precision medicine and related software industry.

Based on end user, the global precision medicine software market is categorized into healthcare providers, research and government institutes, and pharmaceutical & biotechnology companies. In 2020, the healthcare providers segment accounted for the largest share of the global precision medicine software market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of chronic diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine.

An in-depth analysis of the geographical scenario of the precision medicine software market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2020, North America commanded the largest share of the global precision medicine software market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific region is expected to register the highest growth during the forecast period. The growing shift in treatment from one-size-fits-all medicines to precision medicine, increased spending on healthcare, rising funds for research activities, and growing focus of international players to expand their presence in this region are some of the key factors expected to propel the growth of the precision medicines software market in Asia-Pacific.

The key players operating in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), GenomOncology LLC (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One (U.S.), PhenoTips (Canada), PierianDx (U.S.), Foundation Medicine, Inc. (U.S.), and 2bPrecise (U.S.), among others.

Scope of the Report:

Global Precision Medicine Software Market, by Deployment Mode

  • On-premise
  • Web & Cloud-based

Global Precision Medicine Software Market, by Application

  • Oncology
  • Pharmacogenomics
  • Other Applications

Global Precision Medicine Software Market, by End User

  • Healthcare Providers
  • Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies

Global Precision Medicine Software Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Key questions answered in the report-

  • Which are the high growth market segments in terms of deployment mode, application, end-users, and region/countries?
  • What was the historical market for precision medicine software across the globe?
  • What are the market forecasts and estimates for the period 2021-2028?
  • What are the major drivers, restraints, opportunities, and challenges in the global precision medicine software market?
  • Who are the major players in the precision medicine software market?
  • How is the competitive landscape, and who are the market leaders in the global precision medicine software market?
  • What are the recent developments in the global precision medicine software market?
  • What are the different strategies adopted by the major players in the global precision medicine software market?
  • What are the geographical trends and high growth regions/ countries?

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for this Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Paradigm Shift in Treatment
      • 4.2.1.2. Rising Pressure to Reduce Healthcare Costs
      • 4.2.1.3. Scientific & Technological Advances in the Genomics Field
      • 4.2.1.4. Growing Focus towards Providing Companion Diagnostics & Biomarkers
      • 4.2.1.5. Rising Prevalence of Cancer
    • 4.2.2. Restraints
      • 4.2.2.1. Lack of Awareness about Precision Medicine Practices
      • 4.2.2.2. Fragmented Healthcare Systems in Developing Countries
    • 4.2.3. Opportunities
      • 4.2.3.1. Emerging Economies
      • 4.2.3.2. Artificial Intelligence in Precision Medicine
    • 4.2.4. Challenges
      • 4.2.4.1. Lack of Reimbursement for Genetic Testing & Precision Medicine
    • 4.2.5. Covid 19 Impact Assessment

5. Global Precision Medicine Software Market, by Deployment Mode

  • 5.1. Introduction
  • 5.2. On-Premise
  • 5.3. Web & Cloud-Based

6. Global Precision Medicine Software Market, by Application

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Pharmacogenomics
  • 6.4. Other Applications

7. Global Precision Medicine Software Market, by End User

  • 7.1. Introduction
  • 7.2. Healthcare Providers
  • 7.3. Research & Government Institutes
  • 7.4. Pharmaceutical & Biotechnological Companies

8. Precision Medicine Software Market, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific (RoAPAC)
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking

10. Company Profiles

  • 10.1. 2bprecise LLC (A Part of Allscripts Healthcare Solutions Inc.)
    • 10.1.1. Business Overview
    • 10.1.2. Financial Overview
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Developments
  • 10.2. PierianDx, Inc.
    • 10.2.1. Business Overview
    • 10.2.2. Product Portfolio
    • 10.2.3. Strategic Developments
  • 10.3. PhenoTips
    • 10.3.1. Business Overview
    • 10.3.2. Product Portfolio
    • 10.3.3. Strategic Developments
  • 10.4. Foundation Medicine, Inc.
    • 10.4.1. Business Overview
    • 10.4.2. Product Portfolio
    • 10.4.3. Strategic Developments
  • 10.5. N-of-One Inc.
    • 10.5.1. Business Overview
    • 10.5.2. Financial Overview
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Developments
  • 10.6. GenomOncology, LLC
    • 10.6.1. Business Overview
    • 10.6.2. Product Portfolio
    • 10.6.3. Strategic Developments
  • 10.7. Translational Software, Inc.
    • 10.7.1. Business Overview
    • 10.7.2. Product Portfolio
  • 10.8. LifeOmic Health, LLC
    • 10.8.1. Business Overview
    • 10.8.2. Product Portfolio
    • 10.8.3. Strategic Developments
  • 10.9. Syapse, Inc.
    • 10.9.1. Business Overview
    • 10.9.2. Product Portfolio
    • 10.9.3. Strategic Developments
  • 10.10. Fabric Genomics, Inc.
    • 10.10.1. Business Overview
    • 10.10.2. Product Portfolio
    • 10.10.3. Strategic Developments
  • 10.11. Sophia Genetics SA
    • 10.11.1. Business Overview
    • 10.11.2. Product Portfolio
    • 10.11.3. Strategic Developments
  • 10.12. Human Longevity, Inc.
    • 10.12.1. Business Overview
    • 10.12.2. Product Portfolio
    • 10.12.3. Strategic Developments
  • 10.13. Sunquest Information Systems, Inc. (A Part of Roper Technologies, Inc.)
    • 10.13.1. Business Overview
    • 10.13.2. Financial Overview
    • 10.13.3. Product Portfolio

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Available Customization

List of Tables

  • Table 1 Global Precision Medicine Software Market: Impact Analysis of Market Drivers (2021-2028)
  • Table 2 Benefits of Precision Medicine from an Individual and Collective Perspective
  • Table 3 Cancer Incidence, by Type, 2020
  • Table 4 Global Precision Medicine Software Market: Impact Analysis of Market Restraints (2021-2028)
  • Table 5 Global Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 6 Companies Offering On-Premises Precision Medicine Software
  • Table 7 Global On-Premise Precision Medicine Software Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 8 Companies Offering Cloud-Based Precision Medicine Software
  • Table 9 Global Cloud-Based Precision Medicine Software Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 10 Global Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 11 Companies Offering Precision Medicine Software for Oncology
  • Table 12 Global Precision Medicine Software Market Size for Oncology, by Country/Region, 2019-2028 (USD Million)
  • Table 13 Companies Offering Precision Medicine Software for Pharmacogenomics
  • Table 14 Global Precision Medicine Software Market Size for Pharmacogenomics, by Country/Region, 2019-2028 (USD Million)
  • Table 15 Companies Offering Precision Medicine Software for Other Applications
  • Table 16 Global Precision Medicine Software Market Size for Other Applications, by Country/Region, 2019-2028 (USD Million)
  • Table 17 Global Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 18 Strategic Developments by Key Companies
  • Table 19 Global Precision Medicine Software Market Size for Healthcare Providers, by Country/Region, 2019-2028 (USD Million)
  • Table 20 Recent Fundings
  • Table 21 Global Precision Medicine Software Market Size for Research & Government Institutes, by Country/Region, 2019-2028 (USD Million)
  • Table 22 Strategic Developments by Key Companies
  • Table 23 Global Precision Medicine Software Market Size for Pharmaceutical & Biotech Companies, by Country/Region, 2019-2028 (USD Million)
  • Table 24 Global Precision Medicine Software Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 25 North America: Precision Medicine Software Market Size, by Country, 2019-2028 (USD Million)
  • Table 26 North America: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 27 North America: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 28 North America: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 29 U.S.: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 30 U.S.: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 31 U.S.: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 32 Canada: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 33 Canada: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 34 Canada: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 35 Europe: Precision Medicine Software Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 36 Europe: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 37 Europe: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 38 Europe: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 39 Germany: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 40 Germany: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 41 Germany: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 42 U.K.: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 43 U.K.: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 44 U.K.: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 45 France: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 46 France: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 47 France: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 48 Number of Cancer Cases (2019 Vs. 2040)
  • Table 49 Italy: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 50 Italy: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 51 Italy: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 52 Spain: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 53 Spain: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 54 Spain: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 55 Covid-19 Cases in European Countries
  • Table 56 RoE: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 57 RoE: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 58 RoE: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 59 Asia-Pacific: Precision Medicine Software Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 60 Asia-Pacific: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 61 Asia-Pacific: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 62 Asia-Pacific: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 63 Japan: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 64 Japan: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 65 Japan: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 66 China: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 67 China: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 68 China: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 69 India: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 70 India: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 71 India: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 72 RoAPAC: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 73 RoAPAC: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 74 RoAPAC: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 75 Latin America: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 76 Latin America: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 77 Latin America: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 78 Middle East & Africa: Precision Medicine Software Market Size, by Deployment Mode, 2019-2028 (USD Million)
  • Table 79 Middle East & Africa: Precision Medicine Software Market Size, by Application, 2019-2028 (USD Million)
  • Table 80 Middle East & Africa: Precision Medicine Software Market Size, by End User, 2019-2028 (USD Million)
  • Table 81 Recent Developments, by Company, 2018-2021

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Precision Medicine Software Market Size, by Deployment Mode, 2021 Vs. 2028 (USD Million)
  • Figure 8 Global Precision Medicine Software Market Size, by Application, 2021 Vs. 2028 (USD Million)
  • Figure 9 Global Precision Medicine Software Market Size, by End User, 2021 Vs. 2028 (USD Million)
  • Figure 10 Precision Medicine Software Market, by Region
  • Figure 11 Market Dynamics
  • Figure 12 Paradigm Shift in Treatment from One-Size-Fit-All Medicine to Precision Medicine
  • Figure 13 Global Genomics Annual Funding (USD Million)
  • Figure 14 Global Precision Medicine Software Market Size, by Deployment Mode, 2021vs 2028 (USD Million)
  • Figure 15 Global Precision Medicine Software Market Size, by Application, 2021-2028 (USD Million)
  • Figure 16 Global Precision Medicine Software Market Size, by End User, 2021-2028 (USD Million)
  • Figure 17 Global Precision Medicine Software Market, by Region, 2019-2028 (USD Million)
  • Figure 18 Geographic Snapshot: North American Precision Medicine Software Market
  • Figure 19 Estimated Cancer Incidence in the U.S., 2000-2030 (Number of Cases)
  • Figure 20 Geographic Snapshot: European Precision Medicine Software Market
  • Figure 21 Geographic Snapshot: Asia-Pacific Precision Medicine Software Market
  • Figure 22 Key Growth Strategies Adopted by Leading Players, 2018-2021
  • Figure 23 Precision Medicine Software: Competitive Benchmarking, by Deployment Mode
  • Figure 24 Precision Medicine Software: Competitive Benchmarking, by Application
  • Figure 25 Allscripts Healthcare Solutions, Inc: Financial Overview (2020)
  • Figure 26 Qiagen N.V.: Financial Overview (2020)
  • Figure 27 Roper Technologies, Inc.: Financial Overview (2020)